Cited by

• Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

  Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E, Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O, Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S, Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C. Gately L, et al. J Neurooncol. 2024 Jun;168(2):299-306. doi: 10.1007/s11060-024-04668-5. Epub 2024 Apr 17. J Neurooncol. 2024. PMID: 38630385 Clinical Trial.
• Oral anticancer drugs in the elderly: an overview.

  Lonardi S, Bortolami A, Stefani M, Monfardini S. Lonardi S, et al. Drugs Aging. 2007;24(5):395-410. doi: 10.2165/00002512-200724050-00004. Drugs Aging. 2007. PMID: 17503896 Review.
• The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer.

  Castagneto B, Di Pietrantonj C, Stevani I, Anfossi A, Arzese M, Giorcelli L, Giaretto L. Castagneto B, et al. Med Oncol. 2013 Dec;30(4):708. doi: 10.1007/s12032-013-0708-3. Epub 2013 Aug 31. Med Oncol. 2013. PMID: 23996243
• Assessment and treatment relevance in elderly glioblastoma patients.

  Bauchet L, Zouaoui S, Darlix A, Menjot de Champfleur N, Ferreira E, Fabbro M, Kerr C, Taillandier L. Bauchet L, et al. Neuro Oncol. 2014 Nov;16(11):1459-68. doi: 10.1093/neuonc/nou063. Epub 2014 May 2. Neuro Oncol. 2014. PMID: 24792440 Free PMC article. Review.
• Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment.

  Lütgendorf-Caucig C, Freyschlag C, Masel EK, Marosi C. Lütgendorf-Caucig C, et al. Curr Oncol Rep. 2020 Jul 10;22(9):93. doi: 10.1007/s11912-020-00951-6. Curr Oncol Rep. 2020. PMID: 32651730 Free PMC article. Review.